Board summary
Key figures
37,153
Registered population
61.1% aged 18–64
16.0%
Aged 65+
ICB 14.9% · England 17.9%
18.4%
Ethnic minority (non-White)
11.9% Asian · England 9.6%
70.9%
In IMD quintile 1
ICB 40.7% · England 21.0%
~25,831
Core20 residents (est.)
Resident basis; registered basis ~27,407 · see page 3
5,933
Hypertension register
+3.32% in 3 yrs · England +5.60%
472
SMI register
13% of Bolton (LAD)'s
1,603
COPD register
Reviews -1.19% in 3 yrs
Forecast to 2030
6,361
Hypertension patients, 2030
+428 on today
71.0%
QRISK ≥20% on statins, 2030
+1.58pp over 3 yrs
3.4%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma reviews lag England despite high burden.
Annual asthma reviews reach 59.3% (vs 65.7% England) across 2,504 patients, leaving a scale gap of 1,019 (about 1,000) without a recorded review.
Practice phone access and vaccination vary sharply.
Phone contact spans 26.8 pp from 51.1% at Kearsley Medical Centre to 77.9% at Farnworth Family Practice, while QOF vaccination spans 44.4 pp.
Under-80 blood pressure control outpaced England.
Blood pressure control under age 80 rose +8.0 pp (England +2.1 pp) to 66.8%, and QRISK ≥ 20% lipid therapy reaches 67.7% (England 63.6%).
Population, age and ethnicity
Children comprise 22.8% and older adults 16.0% across 37,153 registered patients
Farnworth & Kearsley PCN has 37,153 registered patients. Children aged 0-17 comprise 22.8% (Bolton 23.7%, ICB 21.8%, England 19.6%), while 16.0% (5,951 patients) are aged 65+ (Bolton 14.7%, ICB 14.9%, England 17.9%). Residential Census data shows 81.6% White and 11.9% Asian or Asian British residents, against 72.0% and 20.1% in Bolton, 76.4% and 13.6% in the ICB, and 81.1% and 9.6% nationally. Unadjusted dementia prevalence is 0.7% (273 patients; gap of +6 to +18 against borough and England benchmarks). ONS list growth to 2030 is projected at 0.6% (methodology unverified).
Age profile
65+: ICB 14.9%, England 17.9%
Ethnicity
Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Bolton LA) | 1,923 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 71.6% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 54.8% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Bolton LA) | 958 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Bolton LA) | 19.0 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 covers 70.9% of registered patients with a sharp 40.7 pp practice spread
Core20 covers 70.9% of registered patients, exceeding Bolton (LAD) at 47.8%, the ICB at 40.7%, and England at 21.0%. Average IMD decile is 2.7 against 5.5 in England. Practice concentration spans 40.7 pp, from 50.5% at Kearsley Medical Centre to 91.2% at Fig Tree Medical Practice. Absolute volume centres on Stonehill Medical Centre, with an estimated 12,257 Core20 patients. Weighted practice share of 73.8% differs from the PCN figure by 2.85 pp. Outreach planning therefore needs to balance high-concentration practices with high-volume caseloads.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
472
SMI register
1.27% recorded prevalence
291
Learning disability register
0.78% recorded prevalence
4
Care homes, 208 beds
In the PCN catchment
9.8%
Provide unpaid care
Bolton (LAD), Census 2021
Recorded prevalence is 1.3% for severe mental illness (472 patients) and 0.8% for learning disabilities (291 patients), exceeding Bolton (1.1% and 0.6%), the ICB (1.1% and 0.6%) and England (1.0% and 0.6%). The catchment includes 4 care homes with 208 beds, though resident registrations are unconfirmed. As SMI and learning disability registers exceed national rates, proactive physical health checks across these cohorts remain an inclusion-health workload to sustain.
Severe mental illness: physical health checks
SMI checks trail England: blood pressure recording is 82.6% (England 83.4%; Kearsley Medical Centre 75.3%) and BMI is 80.5% (England 82.1%; Kearsley Medical Centre 67.3%). Individual checks do not establish complete health checks.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,933
Hypertension register
+3.32%
Register growth, 3 yrs
Bolton (LAD) +4.70% · England +5.60%
+7.95pp
BP control, under 80
≤140/90 · +3.87pp aged 80+
+428
More patients by 2030
Forecast 6,361 (17.05%)
Hypertension case-finding and control
Recorded hypertension prevalence is 16.0% (5,933 patients), above Bolton (LAD) (14.8%), NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%). Blood pressure control under 80 improved +8.0 pp over three years (England +2.1 pp) to 66.8%, trailing Bolton (LAD) (67.3%), NHS Greater Manchester Integrated Care Board (68.6%) and England (67.8%), with Kearsley Medical Centre at 64.1%. Patients treated to target rose +7.6 pp over three years to 69.1% (England 70.3%). Denominators include personalised care adjustments. Rapid control gains leave the PCN trailing comparators, suggesting that prioritising recall and blood pressure titration at Kearsley Medical Centre may help close the gap.
Lipids and statins
Lipid-lowering therapy for QRISK ≥ 20% reaches 67.7%, exceeding Bolton (LAD) (63.0%), NHS Greater Manchester Integrated Care Board (67.0%) and England (63.6%), though three-year growth (+2.4%) trailed England (+6.2%). Higher coverage indicates sound primary prevention reach, while slower growth suggests audits could focus on sustaining high-risk review.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 70,842 | £1.90 | £1.94 | £1.86 | £134,600 |
| Cardiovascular (all), 2025 | 95,626 | £3.49 | £3.15 | £3.33 | £333,735 |
For lipid-regulating drugs in 2026, the PCN prescribed 70,842 items at £1.90 per item (Bolton (LAD) £1.81, NHS Greater Manchester Integrated Care Board £1.94, England £1.86), spending £2,834 more than at England's unit cost. Unit cost does not measure prescribing efficiency, but reviewing formulary choices could help optimise expenditure.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+4.41%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−0.06%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 4.3% (1,603 patients; +42.0% over three years vs +2.6% England) and asthma is 7.2% (2,504 patients vs 6.6% England), with child asthma prescribing at 2,903 per 1,000 (vs 1,488 England). However, 12-month reviews lag England for COPD (70.6% vs 76.4%) and asthma (59.3% vs 65.7%; a gap of about 1,000 patients), while child second-hand smoke recording is 69.0% (vs 78.8% England). High disease burden alongside lagging reviews suggests review recall and smoke recording warrant prioritisation.
Cancer register and children's immunisation
The cancer register records 1,150 patients (3.1% vs 3.8% England; +5.2% over three years vs +9.0% England). While 12-month 6-in-1 uptake is 95.6% (vs 91.0% England), age-5 MMR2 coverage is 83.8%, falling below the 95.0% target by 11.2 pp with a 5.7 pp gap from same-cohort MMR1 (89.5%). Strong infant completion contrasts with lower pre-school booster uptake, suggesting potential for targeted pre-school recall.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Greater Manchester ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,270
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Greater Manchester ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Lung | 40.4% | 33.8% | 15% | 2,193 |
| Prostate | 61.7% | 53.2% | 14% | 1,788 |
| Breast | 82.5% | 85.4% | 19% | 1,758 |
| Bowel | 46.3% | 47.0% | 19% | 1,427 |
| Skin cancer | 84.5% | 87.8% | 27% | 580 |
Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2, compared with 55.3% in England, showing a distance of -19.4 pp to the 75.0% national ambition by 2028. Closing that gap represents about 2,270 additional early-stage cases across the ICB. Known-stage coverage was 70.8% (11,679 of 16,492; England 67.0%), while bowel (46.3%) and lung (40.4%) trailed breast (82.5%). Small cohorts such as anus (29 of 57) warrant caution. Staging reflects system pathways rather than PCN performance; locally, cervical screening was 67.0% with a three-year change of -2.0%.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
At Bolton NHS Foundation Trust in July 2026, 62-day cancer treatment reached 69.7%, trailing the 85.0% standard by 15.3 pp, below Manchester University NHS Foundation Trust (72.8%), Northern Care Alliance NHS Foundation Trust (78.6%), NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). Conversely, the 28-day faster diagnosis standard reached 80.5% (standard 75.0%), exceeding Northern Care Alliance NHS Foundation Trust (75.2%), the ICB (79.5%) and England (79.3%). In diagnostics, Bolton's 6-week waits reached 19.4% for computed tomography (England 9.9%) and 25.3% for cystoscopy, while colonoscopy was 1.3% against 30.8% across England.
| Pathways within standard (%) | Bolton | Northern Care Alliance | Manchester | Greater Manchester ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 80.48 | 75.20 | 80.06 | 79.53 | 79.32 |
| 31-day treatment (96%) | 96.50 | 94.54 | 92.54 | 96.49 | 92.50 |
| 62-day referral to treatment (85%) | 69.66 | 78.65 | 72.85 | 75.73 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Bolton | Northern Care Alliance | Manchester | England |
|---|---|---|---|---|
| MRI | 2.05 | 5.09 | 11.68 | 21.40 |
| CT | 19.40 | 4.10 | 14.66 | 9.92 |
| Echocardiography | 3.48 | 31.48 | 4.91 | 28.48 |
| Colonoscopy | 1.33 | 40.04 | 4.51 | 30.83 |
| Gastroscopy | 2.06 | 36.48 | 29.35 | 29.02 |
| All 15 DM01 tests | 15.78 | 15.71 | 8.98 | 23.14 |
| Community services activity | Bolton residents | Greater Manchester ICB |
|---|---|---|
| Care contacts | 49,315 | 573,310 |
| Referrals | 4,075 | 94,470 |
| Patients with a contact | 17,765 | 183,535 |
Community services (residents of Bolton), Jun 2026 (provisional). In June 2026, community health service contacts for Bolton residents totaled 49,315, with adults aged 65 and over accounting for 25,460 contacts, or 51.6% of all recorded activity. These figures reflect borough-wide resident service usage rather than PCN-specific delivery, indicating older-age community health service use across the local authority footprint.
Practice variation and patient experience
Practice vaccination achievement spans 44.4 pp and phone access varies by 26.8 pp
QOF vaccination achievement spans 44.4 pp, from 26.3% at Stonehill Medical Centre to 70.7% at Farnworth Family Practice (England 55.2%). While Stonehill Medical Centre reached 100.0% in the clinical domain, its all-domain personalised care adjustment rate reached 14.0% (England 10.0%). Kearsley Medical Centre recorded 81.4% overall QOF achievement against England's 92.5%.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Farnworth | 117 | 90.4 | 77.9% | 84.3% | 88.7% |
| Kearsley | 124 | 50.5 | 51.1% | 76.9% | 78.3% |
| Stonehill | 109 | 83.5 | 55.8% | 81.7% | 73.7% |
| Fig Tree Medical | 100 | 91.2 | 76.0% | 69.7% | 72.2% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Eighteen of 25 measures trail England over three years despite blood pressure gains
Across 25 tracked measures, 18 trail England over three years. Heart failure reviews fell 2.6% (Bolton (LAD) -1.4%, NHS Greater Manchester Integrated Care Board +2.1%, England +8.7%), psychosis alcohol recording fell 4.5 pp (Bolton (LAD) +1.4 pp, England +5.4 pp), and COPD reviews fell 1.2% (Bolton (LAD) -1.0%, England +2.8%). In contrast, hypertension control under 80 rose +13.5% (Bolton (LAD) +1.0%, England +3.2%) and patients treated to target rose +12.3% (Bolton (LAD) +0.8%, England +3.6%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Depression register
Alcohol record (psychosis)
BMI record (SMI)
COPD reviews
BP control, under 80
Hypertension treated to target
BP control, 80+
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Bolton (LAD) | Asset | PCN | Bolton (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 4 (208 beds) | n/a | Schools (catchment) | 36 | n/a |
| Children's centres | 3 | 18 | Places of worship | 20 | 144 |
| Libraries | n/a | 7 | Primary schools (LA maintained) | 11 | 61 |
| Primary academies | 4 | 32 | Special schools | n/a | 3 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured respiratory and asthma review recall
Asthma reviews reach 59.3% (vs 65.7% England; scale gap 1,019, about 1,000 of 2,504 patients) and COPD reviews reach 70.6% (vs 76.4% England across 1,603 patients). For discussion: the PCN could run single-template asthma and COPD recall, adding after-school slots and second-hand smoke recording (69.0% vs 78.8% England). Moderate effort to run.
Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.
Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.
Option 2
Dementia coding and case-finding audit
Recorded dementia prevalence is 0.7% (273 of 37,153 patients vs 0.7% Bolton (LAD) and 0.8% England; 3-year change +4.7% vs +6.0% England), giving an unadjusted benchmark range of +6 to +18. Low cost, quick to run.
Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.
Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.
Option 3
SMI health checks and access review
Across 472 SMI patients (1.3% vs 1.0% England), BMI recording is 80.5% (England 82.1%; Kearsley Medical Centre 67.3%), BP is 82.6% (Kearsley Medical Centre 75.3%), and psychosis alcohol recording fell 4.5 pp (England +5.4 pp) to 73.9%. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Older adult dementia register review (p2) | Dementia: QOF prevalence | 66.7% diagnosis ambition · 95% care plan 2027 | PCN |
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check recall (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension blood pressure control review (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Telephony and triage capacity review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured respiratory and asthma review recall (p12) | COPD register · COPD: QOF prevalence · Asthma register | Core20PLUS5 respiratory | PCN |
| Option 2 · Dementia coding and case-finding audit (p12) | Dementia register · Dementia: QOF prevalence · Aged 65+ | 66.7% diagnosis ambition · 95% care plan 2027 | PCN |
| Option 3 · SMI health checks and access review (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
